{
"id":"mk19_a_gm_t55",
"number":55,
"bookId":"gm",
"title":{
"__html":"Pharmacotherapy for Opioid Use Disorder"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"00af95",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 55. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_gm_t55"
}
]
},
"Pharmacotherapy for Opioid Use Disorder"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"353bd6",
"class":"col hd l",
"children":[
"Medication"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8ae2a5",
"class":"col hd l",
"children":[
"Uses"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b831dc",
"class":"col hd l",
"children":[
"Side Effects and Risks"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6b0217",
"class":"col hd l",
"children":[
"Precautions"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f4c6f8",
"class":"col hd l",
"children":[
"Notes"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4cf38f",
"class":"cell txt l",
"children":[
"Methadone"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6a0d11",
"class":"cell txt l",
"children":[
"Medication-assisted treatment for OUD"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6d5a81",
"class":"cell txt l",
"children":[
"Sedation, prolongation of the QT interval; similar to other opioids in terms of long-term use"
]
},
" ",
{
"type":"p",
"hlId":"9dc996",
"class":"cell txt l",
"children":[
"Risk for respiratory depression and overdose"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8241e5",
"class":"cell txt l",
"children":[
"Prolonged, variable half-life with incomplete cross-tolerance with other opioids; requires low initiation dose and slow titration"
]
},
" ",
{
"type":"p",
"hlId":"6e2e00",
"class":"cell txt l",
"children":[
"Potential for drug interactions with inducers or inhibitors of the P450 system"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b7afe4",
"class":"cell txt l",
"children":[
"U.S. schedule II"
]
},
" ",
{
"type":"p",
"hlId":"a342c3",
"class":"cell txt l",
"children":[
"For outpatient addiction treatment, only available through state-licensed programs"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1d341d",
"class":"cell txt l",
"children":[
"Buprenorphine-naloxone"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6a0d11",
"class":"cell txt l",
"children":[
"Medication-assisted treatment for OUD"
]
},
" ",
{
"type":"p",
"hlId":"db67c8",
"class":"cell txt l",
"children":[
"Pain management for patients with concurrent OUD and pain syndromes requiring opioids (e.g., cancer-related pain)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"37a09e",
"class":"cell txt l",
"children":[
"Nausea, constipation, headache, insomnia"
]
},
" ",
{
"type":"p",
"hlId":"292916",
"class":"cell txt l",
"children":[
"Decreased risk for overdose; naloxone component activates if patient injects medication"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0a4436",
"class":"cell txt l",
"children":[
"Risk for precipitated opioid withdrawal if initiated too soon in opioid-tolerant patient after last use of full opioid agonist"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"deeb9e",
"class":"cell txt l",
"children":[
"U.S. schedule III"
]
},
" ",
{
"type":"p",
"hlId":"0d5dc4",
"class":"cell txt l",
"children":[
"Requires specialized training (8-hour course) to obtain federal waiver to prescribe"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6b6106",
"class":"cell txt l",
"children":[
"Buprenorphine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"145a93",
"class":"cell txt l",
"children":[
"Inpatient withdrawal management"
]
},
" ",
{
"type":"p",
"hlId":"f51935",
"class":"cell txt l",
"children":[
"Maintenance, particularly for pregnant women"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"37a09e",
"class":"cell txt l",
"children":[
"Nausea, constipation, headache, insomnia"
]
},
" ",
{
"type":"p",
"hlId":"846337",
"class":"cell txt l",
"children":[
"Rarely associated with overdose, usually in combination with other sedating agents"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"091ccf",
"class":"cell txt l",
"children":[
"Risk for precipitated opioid withdrawal if initiated too soon after last use of full opioid agonist"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"deeb9e",
"class":"cell txt l",
"children":[
"U.S. schedule III"
]
},
" ",
{
"type":"p",
"hlId":"72dbe7",
"class":"cell txt l",
"children":[
"Requires federal waiver"
]
},
" ",
{
"type":"p",
"hlId":"0ce22d",
"class":"cell txt l",
"children":[
"Once-monthly injection formulation available"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"514561",
"class":"cell txt l",
"children":[
"Naltrexone"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7c78eb",
"class":"cell txt li",
"children":[
"IM"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"10d0de",
"class":"cell txt l",
"children":[
"Maintenance"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e2311f",
"class":"cell txt l",
"children":[
"Nausea, fatigue, dizziness, injection site reaction"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4f06bf",
"class":"cell txt l",
"children":[
"Risk for overdose if a dose is missed and the patient relapses"
]
},
" ",
{
"type":"p",
"hlId":"6ea7a7",
"class":"cell txt l",
"children":[
"Periodic monitoring of liver enzymes is recommended; impaired metabolism in liver disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b1665a",
"class":"cell txt l",
"children":[
"Some variability in length of time for full opioid blockade"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1dfec3",
"class":"cell txt li",
"children":[
"Oral"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6b332c",
"class":"cell txt l",
"children":[
"Bridge before IM naltrexone; maintenance in highly supervised settings"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3c07da",
"class":"cell txt l",
"children":[
"Nausea, headache, dizziness, elevated aminotransferase levels"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6ea7a7",
"class":"cell txt l",
"children":[
"Periodic monitoring of liver enzymes is recommended; impaired metabolism in liver disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"IM = intramuscular; OUD = opioid use disorder."
],
[
"Adapted with permission from Pace CA, Samet JH. In the clinic. Substance use disorders. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://www.acpjournals.org/doi/10.7326/AITC201604050",
"target":"_blank"
},
"children":[
"Ann Intern Med"
]
},
". 2016;164:ITC58-ITC59. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27043992",
"target":"_blank"
},
"children":[
"PMID: 27043992"
]
},
". Â© 2016, American College of Physicians."
]
]
}